Search results for: 'drug learning enterprise market validation'

The dynamic threat environment has made it difficult for enterprises to continuously validate whether their infrastructure and security controls remain effective. This is because traditional assessment methods, such as annual penetration tests, compliance audits, and vulnerability scanning, were not designed to address identity sprawl, threat compl...

Enterprise network services in 2026 are transitioning to AI-driven, software-defined digital infrastructure as price compression in legacy connectivity persists despite rapid traffic growth. Providers are embedding automation, observability, and advanced security options, including zero trust and integrated SASE frameworks, into programmable, outco...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

The skyrocketing volume of medical imaging data and need to better manage medical images is becoming imperative for healthcare providers. The collaborative HIMSS-SIIM Enterprise Imaging Workgroup de?nes enterprise imaging as “a set of strategies, initiatives, and work?ows implemented across a healthcare enterprise to consistently and optimally capt...

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...

The enterprise network services space is a mature competitive market, with growth expected between 1% and 3% globally in the coming years. Industry participants contribute hundreds of millions and even billions of dollars in network investments and pursue local partners to fulfill and execute their end-to-end solutions. In this market, portfolios m...

Mobile operators are moving rapidly toward 5G network deployments, representing a fundamental shift in communication network architectures that will accelerate revenue generation through innovative services facilitated by 5G-enabled smartphones, tablets, laptops, and Internet of Things (IoT) devices. It delivers a potent combination of network capa...

05 Sep 2022  |  Global  |  Technology Research

Technology Growth Opportunities for Exosome-Mediated Drug Delivery

Exosomes Are Promising Delivery Carriers for Advanced Therapeutics

Infographics

×

Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...

25 Jan 2022  |  Asia Pacific  |  Market Research

Southeast Asia Enterprise Mobility Management Growth Opportunities

Strategic Imperatives Include Mega Trends, Disruptive Technologies, and Innovative Business Models

Infographics

×

Enterprise mobility management (EMM) is software used to securely manage the endpoints of an enterprise. Endpoints can include desktops, computers, laptops, tablets, smartphones, wearables, and the Internet of Things that employees use to access enterprise resources. Enterprise IT must implement a strategy to manage all enterprise devices, bring yo...